Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Total Liabilities (2016 - 2026)

SANUWAVE Health has reported Total Liabilities over the past 17 years, most recently at $35.3 million for Q1 2026.

  • Quarterly Total Liabilities fell 31.76% to $35.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $35.3 million through Mar 2026, down 31.76% year-over-year, with the annual reading at $35.7 million for FY2025, 22.19% down from the prior year.
  • Total Liabilities was $35.3 million for Q1 2026 at SANUWAVE Health, down from $35.7 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $86.3 million in Q3 2023 and troughed at $35.3 million in Q1 2026.
  • The 5-year median for Total Liabilities is $55.1 million (2022), against an average of $59.1 million.
  • Year-over-year, Total Liabilities skyrocketed 59.54% in 2023 and then tumbled 47.4% in 2025.
  • A 5-year view of Total Liabilities shows it stood at $60.9 million in 2022, then grew by 7.74% to $65.6 million in 2023, then plummeted by 30.0% to $45.9 million in 2024, then fell by 22.19% to $35.7 million in 2025, then fell by 1.3% to $35.3 million in 2026.
  • Per Business Quant, the three most recent readings for SNWV's Total Liabilities are $35.3 million (Q1 2026), $35.7 million (Q4 2025), and $43.2 million (Q3 2025).